Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2CNS 1

Conditions

Obesity 5Polycystic Ovary Syndrome 3Sexual Infantilism 2Overweight 2Weight Loss 1Fatty Liver 1Craniopharyngioma 1

Interventions

Exercise 6Nutrition Assessment 4Counseling 4Methods 3Caloric Restriction 3Tirzepatide 2Resistance Training 2Naltrexone 2Metformin 2Megestrol Acetate 2Exenatide 2Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2semaglutide 1licogliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Trehalase 1Tablets 1Standard of Care 1Psychology, Positive 1Propofol 1Progestins 1Patient Navigation 1Motivational Interviewing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Overweight × Exenatide × Other × Clear all
NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

RenJi Hospital

Phase 4 Completed
183 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡